A strategy for modeling this type of preclinical assessment would be the co-culture of ex vivo resected tumors with autologous NK cells to ascertain if the mere presence of an increasing NK cell population would be sufficient for clearance of CALR-expressing tumor cells. The gene discussed is CALR; the disease is neoplasm.